Srf Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of SRF Ltd is ₹ 2568 as of 18 Mar 15:30 . The P/E Ratio of SRF Ltd changed from 27.2 on March 2021 to 69.9 on March 2025 . This represents a CAGR of 20.78% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of SRF Ltd changed from ₹ 32030 crore on March 2021 to ₹ 87129 crore on March 2025 . This represents a CAGR of 22.16% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of SRF Ltd for the Dec '25 is ₹ 3739 crore as compare to the Sep '25 revenue of ₹ 3665 crore. This represent the growth of 2.02% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of SRF Ltd for the Dec '25 is ₹ 734.06 crore as compare to the Sep '25 ebitda of ₹ 799.86 crore. This represent the decline of -8.23% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of SRF Ltd changed from ₹ 252.22 crore to ₹ 432.66 crore over 7 quarters. This represents a CAGR of 36.12% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of SRF Ltd changed from 15.63 % on March 2021 to 16.89 % on March 2025 . This represents a CAGR of 1.56% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About SRF Ltd

SRF Limited is a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates.
The Company is a market leader in most of its business segments in India and overseas.
The Company has operations in four countries, India, Thailand, South Africa, and Hungary.
SRF has commercial interests in more than ninety countries and classifies its businesses as Technical Textiles Business (TTB), Chemicals Business (CB), Packaging Films Business (PFB), and Other Businesses.
The principal activities of the Company are manufacturing, purchase and sale of technical textiles, chemicals, packaging films and other polymers. SRF Limited (SRF) was incorporated on 9th January 1970 under the name of Shriram Fibres Ltd. The change in name of the Company was made in year 1990 from Shriram Fibres Limited to the present name SRF Limited.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of SRF Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, SRF Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of SRF Ltd is 76,124 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,766 Cr

What are the key factors driving the stock performance of SRF Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of SRF Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for SRF Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 18, 2026, the SRF Ltd stock price is INR ₹2568.1. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1182.85.

How do dividend payouts of SRF Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of SRF Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.